These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 11455341)

  • 1. Diffuse neuroendocrine system and mitochondrial diseases: molecular and cellular bases of pathogenesis, new approaches to diagnosis and therapy.
    Kvetnoy IM; Hernández-Yago J; Hernández JM; Kvetnaia TV; Reiter RJ; Khavinson VK
    Neuro Endocrinol Lett; 2000; 21(2):83-99. PubMed ID: 11455341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
    Sas K; Robotka H; Toldi J; Vécsei L
    J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extrapineal melatonin in pathology: new perspectives for diagnosis, prognosis and treatment of illness.
    Kvetnoy I
    Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():92-6. PubMed ID: 12019360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reciprocal Interactions of Mitochondria and the Neuroimmunoendocrine System in Neurodegenerative Disorders: An Important Role for Melatonin Regulation.
    Polyakova VO; Kvetnoy IM; Anderson G; Rosati J; Mazzoccoli G; Linkova NS
    Front Physiol; 2018; 9():199. PubMed ID: 29593561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential indications for somatostatin analogues: immune system and limphoproliferative disorders.
    Ferone D; Resmini E; Boschetti M; Arvigo M; Albanese V; Ceresola E; Pivonello R; Albertelli M; Bianchi F; Giusti M; Minuto F
    J Endocrinol Invest; 2005; 28(11 Suppl International):111-7. PubMed ID: 16625859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine dysfunction in Sjogren's syndrome.
    Tzioufas AG; Tsonis J; Moutsopoulos HM
    Neuroimmunomodulation; 2008; 15(1):37-45. PubMed ID: 18667798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial drug delivery and mitochondrial disease therapy--an approach to liposome-based delivery targeted to mitochondria.
    Yamada Y; Akita H; Kogure K; Kamiya H; Harashima H
    Mitochondrion; 2007; 7(1-2):63-71. PubMed ID: 17296332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune Diseases: Problems of Pathogenesis, Diagnostics and Treatment.
    Shirinskiy VS
    Russ J Immunol; 1999 Oct; 4(3):261-263. PubMed ID: 12687139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of mitochondria in inherited neurodegenerative diseases.
    Kwong JQ; Beal MF; Manfredi G
    J Neurochem; 2006 Jun; 97(6):1659-75. PubMed ID: 16805775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drugs targeting mitochondrial functions to control tumor cell growth.
    Dias N; Bailly C
    Biochem Pharmacol; 2005 Jul; 70(1):1-12. PubMed ID: 15907809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyglutamine diseases and molecular chaperones.
    Kimura Y; Kakizuka A
    IUBMB Life; 2003 Jun; 55(6):337-45. PubMed ID: 12938736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of neuroendocrine system in the pathogenesis of rheumatic diseases (minireview).
    Imrich R
    Endocr Regul; 2002 Jun; 36(2):95-106. PubMed ID: 12207559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of disease II: cellular protein quality control.
    Outeiro TF; Tetzlaff J
    Semin Pediatr Neurol; 2007 Mar; 14(1):15-25. PubMed ID: 17331880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
    Meredith SC
    Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the ubiquitin conjugation system in the maintenance of mitochondrial homeostasis.
    Neutzner A; Benard G; Youle RJ; Karbowski M
    Ann N Y Acad Sci; 2008 Dec; 1147():242-53. PubMed ID: 19076446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunoneuroendocrine communication network and homeostasis regulation: the use of hormones and neurohormones as immunotherapy].
    Arteaga M; Chavarría A; Morales Montor J
    Rev Invest Clin; 2002; 54(6):542-9. PubMed ID: 12685222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disorders of mitochondrial function.
    Debray FG; Lambert M; Mitchell GA
    Curr Opin Pediatr; 2008 Aug; 20(4):471-82. PubMed ID: 18622207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide and cellular stress response in brain aging and neurodegenerative disorders: the role of vitagenes.
    Calabrese V; Boyd-Kimball D; Scapagnini G; Butterfield DA
    In Vivo; 2004; 18(3):245-67. PubMed ID: 15341181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondria as targets for chemotherapy.
    Gogvadze V; Orrenius S; Zhivotovsky B
    Apoptosis; 2009 Apr; 14(4):624-40. PubMed ID: 19205885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.